Skip to content Skip to navigation

David Myung, MD, PhD

David Myung, MD, PhD

Courtesy Professor
Assistant Professor of Ophthalmology at the Stanford University Medical Center and, by courtesy, of Chemical Engineering
Fellowship, Byers Eye Institute at Stanford, Cornea (2019)
Residency, Byers Eye Institute at Stanford, Ophthalmology (2015)
Internship, Kaiser Permanente Santa Clara Medical Center, Internal Medicine (2012)
MD, Stanford University, Medicine (2011)
PhD, Stanford University, Chemical Engineering (2008)
MS, Stanford University, Chemical Engineering (2006)
BA, Yale University, Molecular, Cellular and Developmental Biology (2000)

Dr. Myung is an Assistant Professor of Ophthalmology at the Byers Eye Institute at Stanford and, by courtesy, of Chemical Engineering. He is a board-certified ophthalmologist and attending physician at the VA Palo Alto Health Care System specializing in cataract and corneal surgery and external diseases of the eye, and is Co-Director of the Ophthalmic Innovation Program, a project-based fellowship in the development and regulatory science of new eye care technologies, as well as the Director of Teleophthalmology at the Byers Eye Institute. Dr. Myung leads an NIH-funded translational research laboratory focused on two areas of clinical need: (1) ophthalmic regenerative medicine through tissue engineering and drug delivery, and (2) global health through mobile technologies and telemedicine. His research group takes an interdisciplinary approach toward fostering regeneration of ocular tissues, by using chemistry to not only build biomimetic cellular architectures but also to target and release bioactive molecules to promote healing. Current projects are directed toward the localized delivery of growth factors and/or stem cells to wound sites, the synthesis of bioactive wound dressings and vehicles, and the creation of biopolymeric tissue scaffolds. Dr. Myung and colleagues also investigate the role of mobile technologies in enabling diagnostics and patient care outside of traditional health care settings. His goal is to challenge current paradigms of eye care delivery through new digital health technologies and telemedicine to increase access to care in resource-limited settings both in the US and abroad.